1 Introduction Parkinsons disease (PD) is a neurodegenerative disease commonly present in middle-aged and elderly populations, with insidious onset and progressive exacerbation
The most common symptoms one may present with is overall fatigue, lethargy, and feeling weak
Hence, glutathione treatment reduces melanin production by the body, which lightens the skin
Furthermore, the enhanced viability, mobility, and invasion capacity of cancer cells are conducive to cancer cell invasion of nerve structure and contribute to the PNI [9]
459,460 The anti-inflammatory effects of GLP-1RAs contribute to the attenuation of atherosclerotic plaque lesion development through various mechanisms
While the body can synthesise glutathione itself, factors such as stress, environmental toxins, and ageing can impair production